SEC-sourced researchBeta
SPRY
ARS Pharmaceuticals, Inc.
Company comparison ↗
Data passport
- CIK
- 0001671858
- Exchange
- Nasdaq
- Business activity
- — · SIC 2834
- Financial inputs
- 6/6
- Filing date
- Nov 9, 2026
- SEC registry record
- Operating company
Annual financial history
Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.
| Period end | Revenue | Filing date |
|---|---|---|
| December 2024 | 89,149,000.0000 | Mar 9, 2026 |
| December 2025 | 84,278,000.0000 | Mar 9, 2026 |
Annual periods · USD
| Period end | Revenue | Net income | Operating cash flow | Total assets | Total liabilities | Filing date |
|---|---|---|---|---|---|---|
| December 2025 | 84,278,000.0000 | -171,298,000.0000 | -170,866,000.0000 | 327,652,000.0000 | 213,394,000.0000 | Mar 9, 2026 |
| December 2024 | 89,149,000.0000 | 7,998,000.0000 | 13,548,000.0000 | 351,153,000.0000 | 94,355,000.0000 | Mar 9, 2026 |
Financial inputs behind the calculation
| Financial inputs | USD | Period end | Filing date | Form |
|---|---|---|---|---|
| RevenueRevenueFromContractWithCustomerExcludingAssessedTax | $84.28M | December 2025 | Mar 9, 2026 | 10-K |
| Previous period revenueRevenueFromContractWithCustomerExcludingAssessedTax | $89.15M | December 2024 | Mar 9, 2026 | 10-K |
| Net incomeNetIncomeLoss | -$171.3M | December 2025 | Mar 9, 2026 | 10-K |
| Operating cash flowNetCashProvidedByUsedInOperatingActivities | -$170.87M | December 2025 | Mar 9, 2026 | 10-K |
| Total assetsAssets | $327.65M | December 2025 | Mar 9, 2026 | 10-K |
| Total liabilitiesLiabilities | $213.39M | December 2025 | Mar 9, 2026 | 10-K |
New filings
- 144SPRY · ARS Pharmaceuticals, Inc.Nov 9, 2026 · Other
- 10-QSPRY · ARS Pharmaceuticals, Inc.Nov 5, 2026 · Periodic
- 8-KSPRY · ARS Pharmaceuticals, Inc.Nov 5, 2026 · Current event
- 4SPRY · ARS Pharmaceuticals, Inc.Nov 4, 2026 · Other
- 3SPRY · ARS Pharmaceuticals, Inc.Nov 4, 2026 · Other
- 144SPRY · ARS Pharmaceuticals, Inc.Oct 30, 2026 · Other
- 144SPRY · ARS Pharmaceuticals, Inc.Oct 19, 2026 · Other
- 4SPRY · ARS Pharmaceuticals, Inc.Oct 5, 2026 · Other
- 144SPRY · ARS Pharmaceuticals, Inc.Oct 1, 2026 · Other
- 144SPRY · ARS Pharmaceuticals, Inc.Sep 30, 2026 · Other